Bicara Therapeutics

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

AC Immune CEO bids adieu—Chutes & Ladders

AC Immune CEO bids adieu. Bicara picks up commercial head from Replimune. Infinimmune names CMO to lead clinical push.
race track

Bicara CEO: ASCO data resonate more with 'people that matter'

Jun 2, 2025 4:26pm
Blue race track

ASCO: Chasing Merus, Bicara shares 2-year HNSCC survival data

Jun 1, 2025 3:36pm
Flexibility and adaptation concept Arrows on cubes following a flexible path

'One of the lucky few': Bicara CEO on last year's $326M IPO

Apr 14, 2025 3:59pm
Court lawsuit legal litigation

Biocon accused of IP theft to create cancer biotech Bicara

Oct 24, 2024 11:04am
Graphic image of the letters IPO in white in front of a yellow background

Zenas, MBX, Bicara head to Nasdaq in hot day for biotech IPOs

Sep 13, 2024 5:25am